Plenary Speakers

• Prof. Richard Callaghan Multi-drug efflux by P-glycoprotein; why has this protein not been stopped yet?
  R. Callaghan, R. Ford, M. O'Mara and I.D. Kerr. Oxford Multidrug Resistance Group, Merton College, Oxford University, UK. Department of Pharmacology and Physiology, School of Medicine and Dentistry, University of Rochester Medical Center, new York 14642, USA.

• Prof. Robert Dirksen, Molecular mechanism of store-operated calcium entry (SOCE) in skeletal muscle and potential role in fatigue resistance.
  R.T. Dirksen, A.D. Lyfenko and L. Wei. Department of Pharmacology and Physiology, School of Medicine and Dentistry, University of Rochester Medical Center, new York 14642, USA.
• Prof. Robert Kass, Chairman and Hosack Professor of Pharmacology, Columbia University, New York, USA. The congenital Long QT Syndrome: broad lessons from a rare disease
• Prof. Erik Richter, Physiology and Exercise Physiology, Copenhagen Muscle Research Centre, Institute of Exercise and Sport Sciences, University of Copenhagen, Denmark. Metabolic regulation in exercise: mechanisms and experimental models
• A/Prof. Dirk van Helden, Principal Research Fellow, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle. Calcium signalling, pacing and rhythmic cell activity.